DIGITAL PET-MRI (AI POWERED)

It is the first digital PET-MR in Asia with a LySO digital PET detector.

90% less radiation exposure compared to conventional PET-CT.

The short scan time of 20 minutes for whole-body imaging.

PET-MR provides excellent human anatomical details coupled with physiological and biochemical information.

One–stop shop for accurate imaging evaluation of HCC, lymphoma, melanoma, prostate cancer, pelvic malignancy, bone and soft tissue tumours.

Extremely useful in the evaluation of suspected tumour recurrence and newly developed metastasis.

The most accurate modality for the diagnosis of brain lesions may be missed in 50% of cases with PET-CT.

Differentiates between viable tissue and areas of necrosis, especially in brain tumours.

Massive potential in neurological disorders, including epilepsy and dementias.

A promising tool for assessment of myocardial viability, cardiac sarcoidosis and amyloidosis.

Accurate quantification of standard uptake values (SUV) and metabolic tumour volume (MTV) are essential to assess treatment response and plan further management.